OpenVSafe by OpenVAERS
Search V-safe

CHK-31325-13688

2 vaccinations 8 coded responses 11 check-ins 8 free-text entries 5 call cases
Sex
Female
Age at first dose
16-20
ZIP prefix
007 / PR
Registered
2022-01-12
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2032350 (opens in a new window) high 11 / 11 — 1 of 2 VAERS symptoms same dose (2) PR matches 2022-01-11 / 2022-01-12 / 2022-01-13
received the same day as the last call
case 48069

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-12-15
    Dose 1 — Pfizer-BioNTech
  2. 2022-01-11
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-12
    Registered in v-safe
  4. 2022-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dysuria, Nasal flaring, Pyrexia, Respiratory disorder, Unevaluable event — Feeling: Poor · Site: Pain · Fever · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Systemic reaction (other): Fever, dysuria, Respiratory Difficulty, Retractions and Nasal Flaring · Healthcare visit (other): Respiratory Treatment q2hrs, IV abd inhaled steroids, IV Antibiotics
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  6. 2022-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea, Hospitalisation, Respiratory therapy, Unevaluable event — Feeling: Poor · Site: Pain · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Systemic reaction (other): Still difficulty breathing, dysutia · Healthcare visit (other): Still hospitalized with oxigen, respiratory treatment, IN and inhaled steroids
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  8. 2022-01-13
  9. 2022-01-13
  10. 2022-01-13
    Call successful
    Completed over the phone
  11. 2022-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hospitalisation — Feeling: Fair · Site: Pain · Fatigue or tiredness · Get care from a doctor or other healthcare professional
    Free text: Released today from hospital
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2022-01-14
    Call successful
    Reported to VAERS during previous contact from GDIT
  14. 2022-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Respiratory disorder — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Impring breathing
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Respiratory symptom — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Improving cough and respiratory symptoms
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2022-01-18
    Call successful
    Reported to VAERS during previous contact from GDIT
  18. 2022-01-20
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities
    Adult check-in
  19. 2022-02-13
    Survey response — day 28, dose 2
    MedDRA: Amenorrhoea — Feeling: Fair
    Free text: No period
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-02-17
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  21. 2022-02-24
    Survey response — day 42, dose 2
    MedDRA: Hypersensitivity, Menstruation delayed, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Delayed in period, hives, allergic reactions
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-02-24
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-02-28
  24. 2022-04-12
    Survey response — 3 months, dose 2
    MedDRA: Menstrual disorder, Menstruation irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Abnormal bleeding, black like, almost constant petiods
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-04-12
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  26. 2022-04-19
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12021-12-15Pfizer-BioNTech No
22022-01-11Pfizer-BioNTech No

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 2

2022-01-12

Systemic reaction (other): Fever, dysuria, Respiratory Difficulty, Retractions and Nasal Flaring
Healthcare visit (other): Respiratory Treatment q2hrs, IV abd inhaled steroids, IV Antibiotics

2022-01-13

Systemic reaction (other): Still difficulty breathing, dysutia
Healthcare visit (other): Still hospitalized with oxigen, respiratory treatment, IN and inhaled steroids

2022-01-14

Healthcare visit (other): Released today from hospital

2022-01-15

Systemic reaction (other): Impring breathing

2022-01-16

Systemic reaction (other): Improving cough and respiratory symptoms

Release 11 — day 28, dose 2

2022-02-13

Symptoms: No period

Release 11 — day 42, dose 2

2022-02-24

Symptoms: Delayed in period, hives, allergic reactions

Release 11 — 3 months, dose 2

2022-04-12

Symptoms: Abnormal bleeding, black like, almost constant petiods

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOHospitalisation · · ✓
HCVORespiratory therapy · · ✓
HCVOUnevaluable event · · ✓
SDAmenorrhoea · · ✓
SDHypersensitivity · · ✓
SDMenstrual disorder · · ✓
SDMenstruation delayed · · ✓
SDMenstruation irregular · · ✓
SDUrticaria · · ✓
SROCough · · ✓
SRODyspnoea · · ✓
SRODysuria · · ✓
SRONasal flaring · · ✓
SROPyrexia · · ✓
SRORespiratory disorder · · ✓
SRORespiratory symptom · · ✓
SROUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release